Ohkubo T, Shimoyama R, Sugawara K
Department of Pharmacy, Hirosaki University Hospital, Japan.
J Chromatogr. 1993 May 5;614(2):328-32. doi: 10.1016/0378-4347(93)80326-y.
A high-performance liquid chromatographic (HPLC) assay was developed for the determination of chlorpromazine in serum and human breast milk. Chlorpromazine in serum and human breast milk was extracted by a rapid and simple procedure based on C18 bonded-phase extraction, and a reversed-phase HPLC separation technique was developed. Chlorpromazine and levomepromazine as the internal standard were detected by ultraviolet absorbance at 254 nm. Determination was possible for chlorpromazine in the concentration range 10-300 ng/ml. The recoveries of chlorpromazine added to serum and human breast milk were 80.1-87.6 and 80.3-84.4%, respectively, with coefficients of variation of less than 10.2 and 7.8%. The method is applicable to drug level monitoring in the serum and human breast milk of patients treated with chlorpromazine.
建立了一种高效液相色谱(HPLC)法测定血清和人母乳中的氯丙嗪。基于C18键合相萃取,采用快速简便的方法提取血清和人母乳中的氯丙嗪,并开发了反相HPLC分离技术。通过在254nm处的紫外吸光度检测氯丙嗪和作为内标的左美丙嗪。氯丙嗪的测定浓度范围为10-300ng/ml。添加到血清和人母乳中的氯丙嗪回收率分别为80.1-87.6%和80.3-84.4%,变异系数分别小于10.2%和7.8%。该方法适用于氯丙嗪治疗患者血清和人母乳中的药物浓度监测。